Provided by Tiger Trade Technology Pte. Ltd.

HCW Biologics Inc.

3.23
-0.2038-5.94%
Volume:40.36K
Turnover:137.52K
Market Cap:5.92M
PE:-0.12
High:3.60
Open:3.60
Low:3.21
Close:3.43
52wk High:36.65
52wk Low:1.50
Shares:1.84M
Float Shares:1.65M
Volume Ratio:0.42
T/O Rate:2.45%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-27.1846
EPS(LYR):-63.7804
ROE:-151.36%
ROA:-13.88%
PB:0.80
PE(LYR):-0.05

Loading ...

Apr 30, 2026

Major Issues Report

Form 8-K - Current report
Apr 30, 2026

Major Issues Report

Form 8-K - Current report
Apr 24, 2026

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Apr 23, 2026

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Apr 17, 2026

Major Issues Report

Form 8-K - Current report
Mar 31, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 31, 2026

Major Issues Report

Form 8-K - Current report
Mar 17, 2026

Major Issues Report

Form 8-K - Current report
Mar 02, 2026

Major Issues Report

Form 8-K - Current report
Feb 19, 2026

Major Issues Report

Form 8-K - Current report
Feb 17, 2026

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Feb 13, 2026

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Feb 13, 2026

Major Issues Report

Form 8-K - Current report
Feb 12, 2026

Correspondence

Form CORRESP - Correspondence
Feb 12, 2026

Correspondence

Form CORRESP - Correspondence
Feb 11, 2026

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Jan 28, 2026

Correspondence

Form CORRESP - Correspondence
Jan 09, 2026

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Dec 31, 2025

Major Issues Report

Form 8-K - Current report
Nov 20, 2025

Major Issues Report

Form 8-K - Current report